Floatz logo

Cipralex

Hyperprolactinemia

Si TianmeiPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hyperprolactinemia cohort.

Asset / SponsorPhaseRating
Risperdal
Si Tianmei
Phase 4BB
CITALOPRAM
Si Tianmei
Phase 4BB
Paliperidone Palmitate 3-Month Formulation
Si Tianmei
Phase 4BB
Sertraline
Si Tianmei
Phase 4BB
Bromocriptin
University Hospital, Bonn
Phase 3B

View all 11 →

Same molecule, other indications

Cipralex is also rated in:

Anxiety DisordersDormant
A
Indicative ·
81 / 100
View asset →
bipolar I disorderDormant
BBB
Indicative ·
77 / 100
View asset →
dysthymic disorderDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →